publication date: Dec. 19, 2010

In this issue: 

Feds set guidelines for pharma to help patients with cost of drugs, while steering clear of anti-kickback law.

Advocacy groups consider pros and cons of forming co-pay foundations.

Download (PDF 719KB)

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.